ARTICLE
14 February 2025

State Healthcare Transaction Laws

SM
Sheppard, Mullin, Richter & Hampton LLP

Contributor

Businesses turn to Sheppard to deliver sophisticated counsel to help clients move ahead. With more than 1,200 lawyers located in 16 offices worldwide, our client-centered approach is grounded in nearly a century of building enduring relationships on trust and collaboration. Our broad and diversified practices serve global clients—from startups to Fortune 500 companies—at every stage of the business cycle, including high-stakes litigation, complex transactions, sophisticated financings and regulatory issues. With leading edge technologies and innovation behind our team, we pride ourselves on being a strategic partner to our clients.
Our interactive map provides an overview of states' pre-merger notification requirements applicable to healthcare transactions (aka "Baby HSR Acts" or "mini-HSRs").
United States Food, Drugs, Healthcare, Life Sciences
Sheppard, Mullin, Richter & Hampton LLP are most popular:
  • within Cannabis & Hemp and Insolvency/Bankruptcy/Re-Structuring topic(s)

1584858b.jpg

Our interactive map provides an overview of states' pre-merger notification requirements applicable to healthcare transactions (aka "Baby HSR Acts" or "mini-HSRs"). Our teamupdates this map regularly, as many states are or will be contemplating legislation that results in new pre-merger notification laws.

  • The map identifies three categories of such notification requirements based on the type of healthcare entity subject to the notification requirement:

1584858a.jpg

  • Note that in many states, healthcare transactions, and particularly regulated healthcare entities, may also be subject to additional review and requirements not identified in this map, such as facility licensure requirements.

  • Finally, and most importantly, this map is intended to serve as a starting point for analyzing whether a transaction would be subject to any pre-merger notification requirements in any state. Accordingly, we invite you to please reach out toour teamwith any questions about potential regulatory approvals for you healthcare transaction, as well as attorneys on ourhealthcareandantitrust and competitionteams.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More